The FEBS/EMBO Women in Science Award, now in its third year, recognizes and rewards the exceptional achievements of a female researcher in molecular biology over the previous five years. Winners of the award are role models who inspire future generations of women in science.
"Ingrid Grummt is an outstanding scientist who has made seminal contributions in the field of regulation of gene expression, including the very recent discoveries that link ageing and some inherited diseases with the silencing of genes required for cell growth," said selection committee member Claudio Sunkel, Director of the Institute of Molecular and Cellular Biology in Porto, Portugal.
The 2010 winner is distinguished not only for scientific contributions but also for her commitment to the development of European science through her active service on various advisory boards, panels and scientific committees.
"It is important to me to inspire young women to face personal and professional challenges, to help them mobilize their strengths when in doubt and motivate and encourage them to keep their eyes on their goals. I think that integrating career and personal goals makes people happier and more productive in the long run," said the award winner.
Prior to joining the German Cancer Research Center, Ingrid was a post-doctoral fellow at the German Academy of Sciences in Berlin and the Max Planck Institute of Biochemistry in Munich, and led a research group at the University in Würzburg, Germany. She was honoured with prestigious awards such as the Science Prize of the Fritz-Winter-Foundation and the Gottfried Wilhelm Leibniz-Prize for German scientists.
The 2010 FEBS/EMBO Women in Science Award of 10,000 euro will be presented to Ingrid Grummt on 30 June at the 35th FEBS Congress in Gothenburg, Sweden, where she will present a special lecture.
The European Molecular Biology Organization (EMBO) promotes excellence in molecular life sciences in Europe by recognizing and fostering talented scientists. Since 1964, leading scientists are elected annually to become EMBO Members based on proven excellence in research. Members number more than 1,400 today. Fifty-three scientists from the EMBO membership have received the Nobel Prize.
Four leading peer-reviewed journals - The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine - span a broad spectrum of topics of molecular biology and reflect how science is shaping the world.EMBO funding, training and networking activities impact thousands of scientists every year, promoting collaboration in all areas of molecular biology - within its 27 member states, in Europe and neighbouring countries, and worldwide.
For more information: www.embo.org
The Federation of European Biochemical Societies (FEBS) is a leading European organization of the life sciences. Its constituent societies, whose membership exceeds 40,000 in Europe and adjoining countries, extend from Ireland and Iceland in the west, to Armenia in the east.
FEBS promotes research and the teaching of biochemistry, molecular cell biology and molecular biophysics, by supporting an annual congress, a rich program of advanced practical and theoretical courses, workshops and special lectures. These activities are complemented by an extensive fellowships program, enabling mobility of young and senior scientists across the European continent.
FEBS has pioneered the creation of scientific publication forums for European life scientists by its two leading journals, FEBS Journal and FEBS Letters.
Being concerned about Europe's scientific future, FEBS has been involved in the establishment of the European Life Science Forum (ELSF) and the Initiative for Science in Europe (ISE), both active in developing new channels and means for advancing science.
CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research
24.05.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden
BMBF funds translational project to improve radiotherapy
10.05.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy